Stockreport

Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green [Yahoo! Finance]

Pyxis Oncology, Inc.  (PYXS) 
PDF The top 10 shareholders own 50% of the company Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock If [Read more]